Background & Aims: Chronic microbial infections are frequently associated with B-cell activation and polyclonal proliferation, potentially leading to autoimmunity and lymphoproliferative disorders. We assessed B-cell phenotype and function in chronic hepatitis B (HBV) and chronic hepatitis C (HCV) virus infection. Methods: We studied 70 patients with chronic HCV infection, 34 with chronic HBV infection and 54 healthy controls. B-cell phenotype was assessed by flow cytometry using monoclonal antibodies specific for CD27, the CD69, CD71, and CD86 activation markers and the chemokine receptor CXCR3. Differentiation into immunoglobulin-producing cells (IPC) was analysed by ELISpot upon stimulation and with CD40 ligand +/- IL-10 as surrogate bystander T-cell help or CpG oligodeoxynucleotide +/- IL-2, as innate immunity signal. Proliferation was examined by flow cytometry using carboxyfluorescein diacetate succinimidyl ester (CFSE) after stimulation with CpG. Results: A significantly higher proportion of B cells from both HCV- and HBV-infected patients expressed activation markers compared with controls and a positive correlation was found between CXCR3(+) B cells and HCV RNA values. Memory B cells from patients with chronic HCV and HBV infections showed enhanced differentiation into IPC compared with controls, although this was restricted to IgG and at a lower level in HCV-compared with HBV-infected patients. Moreover, patients' activated B cells displayed significantly lower proliferative ability compared to healthy donors despite low expression of the FcRL4 exhaustion marker. Conclusions: B-cell activation, but not exhaustion, is common in chronic viral hepatitis. However, enhanced B-cell differentiation and deficient proliferative capacity were not associated with commitment to terminal differentiation. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections / Oliviero B., 80; Antonella, Cerino; Stefania, Varchetta; Enrica, Paudice; Somnath, Pai; Serena, Ludovisi; Marco, Zaramella; Giuseppe, Michelone; Paolo, Pugnale; Francesco, Negro; Barnaba, Vincenzo; Mario U., Mondelli. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - STAMPA. - 55:1(2011), pp. 53-60. [10.1016/j.jhep.2010.10.016]

Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections

BARNABA, Vincenzo;
2011

Abstract

Background & Aims: Chronic microbial infections are frequently associated with B-cell activation and polyclonal proliferation, potentially leading to autoimmunity and lymphoproliferative disorders. We assessed B-cell phenotype and function in chronic hepatitis B (HBV) and chronic hepatitis C (HCV) virus infection. Methods: We studied 70 patients with chronic HCV infection, 34 with chronic HBV infection and 54 healthy controls. B-cell phenotype was assessed by flow cytometry using monoclonal antibodies specific for CD27, the CD69, CD71, and CD86 activation markers and the chemokine receptor CXCR3. Differentiation into immunoglobulin-producing cells (IPC) was analysed by ELISpot upon stimulation and with CD40 ligand +/- IL-10 as surrogate bystander T-cell help or CpG oligodeoxynucleotide +/- IL-2, as innate immunity signal. Proliferation was examined by flow cytometry using carboxyfluorescein diacetate succinimidyl ester (CFSE) after stimulation with CpG. Results: A significantly higher proportion of B cells from both HCV- and HBV-infected patients expressed activation markers compared with controls and a positive correlation was found between CXCR3(+) B cells and HCV RNA values. Memory B cells from patients with chronic HCV and HBV infections showed enhanced differentiation into IPC compared with controls, although this was restricted to IgG and at a lower level in HCV-compared with HBV-infected patients. Moreover, patients' activated B cells displayed significantly lower proliferative ability compared to healthy donors despite low expression of the FcRL4 exhaustion marker. Conclusions: B-cell activation, but not exhaustion, is common in chronic viral hepatitis. However, enhanced B-cell differentiation and deficient proliferative capacity were not associated with commitment to terminal differentiation. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
2011
activation markers; b cells; elispot; flow cytometry; hbv; hcv
01 Pubblicazione su rivista::01a Articolo in rivista
Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections / Oliviero B., 80; Antonella, Cerino; Stefania, Varchetta; Enrica, Paudice; Somnath, Pai; Serena, Ludovisi; Marco, Zaramella; Giuseppe, Michelone; Paolo, Pugnale; Francesco, Negro; Barnaba, Vincenzo; Mario U., Mondelli. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - STAMPA. - 55:1(2011), pp. 53-60. [10.1016/j.jhep.2010.10.016]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/460705
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 61
  • Scopus 125
  • ???jsp.display-item.citation.isi??? 122
social impact